Search - tctmd.com

Displaying 121 - 140 of 156

Sort: Relevancy | Date

News Daily News

CAC Scoring Is Predictive of Risk Across Races and Ethnicities

L.A. McKeown

October 16, 2018

News Daily News

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

Michael O'Riordan

August 13, 2018

News Daily News

Alirocumab Price Slashed in Deal With Express Scripts

Michael O'Riordan

May 03, 2018

News Daily News

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Michael O'Riordan

April 25, 2018

News Daily News

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

Michael O'Riordan

April 24, 2018

News Conference News ACC 2018

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

Michael O'Riordan

March 10, 2018

News Daily News

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

Michael O'Riordan

December 04, 2017

News Daily News

More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA

Michael O'Riordan

October 24, 2017

News Daily News

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

Michael O'Riordan

October 19, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2017

Shelley Wood

September 30, 2017

News Daily News

Quitting Chronic, Low-Dose Aspirin May Boost Risk of Cardiovascular Events

Todd Neale

September 25, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2017

Caitlin E. Cox

August 31, 2017

News Daily News

Evolocumab Not Cost-Effective at Current List Price

Michael O'Riordan

August 23, 2017

News Daily News

Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences

Todd Neale

August 18, 2017

News Daily News

Costs Up, Usage Down: Hospitals Curtailed Use of CV Meds When Prices Soared

Todd Neale

August 15, 2017

News Features

Getting High: The Low-down for Cardiologists on Illicit Drugs and Marijuana

Ashley Lyles

July 13, 2017

News Daily News

Black Men Have Twofold Higher Risk of Dying From First CHD Event

Michael O'Riordan

July 10, 2017

News Daily News

Poor Prescription Adherence After Acute MI Continues to Vex Researchers

L.A. McKeown

June 30, 2017

News Conference News ACC 2017

Many Patients Prescribed PCSK9 Inhibitors Never End Up Getting Them

Yael L. Maxwell

March 23, 2017

News Conference News CRT 2017

Same-Day Discharge After Transradial PCI Safe, Feasible, With Significant Cost Savings

Michael O'Riordan

February 23, 2017

Advertisement

CAC Scoring Is Predictive of Risk Across Races and Ethnicities

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

Alirocumab Price Slashed in Deal With Express Scripts

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

TCTMD’s Top 10 Most Popular Stories for September 2017

Quitting Chronic, Low-Dose Aspirin May Boost Risk of Cardiovascular Events

TCTMD’s Top 10 Most Popular Stories for August 2017

Evolocumab Not Cost-Effective at Current List Price

Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences

Costs Up, Usage Down: Hospitals Curtailed Use of CV Meds When Prices Soared

Getting High: The Low-down for Cardiologists on Illicit Drugs and Marijuana

Black Men Have Twofold Higher Risk of Dying From First CHD Event

Poor Prescription Adherence After Acute MI Continues to Vex Researchers

Many Patients Prescribed PCSK9 Inhibitors Never End Up Getting Them

Same-Day Discharge After Transradial PCI Safe, Feasible, With Significant Cost Savings

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content